• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lyra Therapeutics Inc (NQ: LYRA )

    0.2726 +0.0026 (+0.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Lyra Therapeutics Inc

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million. 
    Via Benzinga
    Lyra Therapeutics's Return On Capital Employed Insights
    According to data from Benzinga Pro, during Q1, Lyra Therapeutics's (NASDAQ:LYRA) reported sales totaled $5.37 million. Despite a 48.51% increase in earnings, the company posted a loss of $7.01... 
    Via Benzinga
    Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor
    Via Benzinga
    Recap: Lyra Therapeutics Q1 Earnings
    Lyra Therapeutics (NASDAQ:LYRA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    7 Stocks to Watch for Major Insider Trading Clues
    These seven stocks show varying degrees of insider trading, which can provide a hint regarding each company or fund's performance. 
    Via InvestorPlace
    Lyra Therapeutics Stock Surges On Equity Raise Of $100M
    Via Benzinga
    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
    Via Benzinga
    Exposures Product Safety
    Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
    Upgrades 
    Via Benzinga
    The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
    Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
    Via Benzinga
    90 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'... 
    Via Benzinga
    Executives Buy More Than $32M Of 4 Stocks
    Although U.S. stock futures traded lower this morning on Monday, there were a few notable insider trades. 
    Via Benzinga
    54 Biggest Movers From Yesterday
    Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to... 
    Via Benzinga
    The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
    Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting... 
    Via Benzinga
    51 Biggest Movers From Thursday
    Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers 
    Via Benzinga
    Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume... 
    Via Benzinga
    28 Stocks Moving In Friday's Mid-Day Session
    Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million. TSR, Inc. (NASDAQ... 
    Via Benzinga
    Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide
    U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday. 
    Via Benzinga
    Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday
    We're diving into the top penny stocks for today in our market update for Friday with all the latest news that's moving shares! 
    Via InvestorPlace
    Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February
    U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is... 
    Via Benzinga
    Lyra Therapeutics Kickstarts LYR-210 Pivotal Program in Surgically Naïve Chronic Rhinosinusitis Patients
    Lyra Therapeutics Inc (NASDAQ: LYRA) has initiated its Phase 3 ENLIGHTEN I trial of LYR-210 in adult, surgically naïve chronic rhinosinusitis (CRS) patients.... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares... 
    Via Benzinga
    Earnings Scheduled For August 9, 2021
    Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.